AAAAAA

   
Results: 1-11 |
Results: 11
Nomograms for the administration of unfractionated heparin
Authors: Grubb, H Lovett, J Kingman, HM Copplestone, JA Prentice, AG
Citation: H. Grubb et al., Nomograms for the administration of unfractionated heparin, THROMB HAEM, 85(3), 2001, pp. 565-565
Oral antifungals as prophylaxis in haematological malignancy
Authors: Prentice, AG Donnelly, P
Citation: Ag. Prentice et P. Donnelly, Oral antifungals as prophylaxis in haematological malignancy, BLOOD REV, 15(1), 2001, pp. 1-8
Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate
Authors: Goddard, RV Prentice, AG Copplestone, JA Kaminski, ER
Citation: Rv. Goddard et al., Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate, CLIN EXP IM, 126(1), 2001, pp. 16-28
Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation
Authors: Scrivener, S Kaminski, ER Demaine, A Prentice, AG
Citation: S. Scrivener et al., Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation, BR J HAEM, 112(4), 2001, pp. 959-964
FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma
Authors: Child, JA Johnson, SA Rule, S Smith, GM Morgan, GJ Johnson, PWM Prentice, AG Tollerfield, SM Wareham, E
Citation: Ja. Child et al., FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma, LEUK LYMPH, 37(3-4), 2000, pp. 309-317
Immunohistochemical detection of plasminogen activator inhibitor-1 in polycystic ovaries
Authors: Atiomo, WU Hilton, D Fox, DHR Lee, D Shaw, S Friend, J Wilkin, TJ Prentice, AG
Citation: Wu. Atiomo et al., Immunohistochemical detection of plasminogen activator inhibitor-1 in polycystic ovaries, GYNECOL END, 14(3), 2000, pp. 162-168
Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS)
Authors: Atiomo, WU Fox, R Condon, JE Shaw, S Friend, JJ Prentice, AG Wilkin, TJ
Citation: Wu. Atiomo et al., Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS), CLIN ENDOCR, 52(4), 2000, pp. 487-492
Are women with polycystic ovary syndrome resistant to activated protein C?
Authors: Atiomo, WU Condon, J Adekanmi, OA Friend, J Wilkin, TJ Prentice, AG
Citation: Wu. Atiomo et al., Are women with polycystic ovary syndrome resistant to activated protein C?, FERT STERIL, 74(6), 2000, pp. 1229-1232
Towards a targeted, risk-based, antifungal strategy in neutropenic patients
Authors: Prentice, HG Kibbler, CC Prentice, AG
Citation: Hg. Prentice et al., Towards a targeted, risk-based, antifungal strategy in neutropenic patients, BR J HAEM, 110(2), 2000, pp. 273-284
British Society for Haematology Slide Session, Annual Scientific Meeting, brighton 1999
Authors: Bain, BJ Haynes, A Prentice, AG Luckit, J Swirsky, D Williams, Y Bain, BJ Bhavnani, M Barton, C Ezekwesili, R
Citation: Bj. Bain et al., British Society for Haematology Slide Session, Annual Scientific Meeting, brighton 1999, CLIN LAB H, 21(6), 1999, pp. 417-425
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies
Authors: Morgenstern, GR Prentice, AG Prentice, HG Ropner, JE Schey, SA Warnock, DW
Citation: Gr. Morgenstern et al., A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies, BR J HAEM, 105(4), 1999, pp. 901-911
Risultati: 1-11 |